Price decreases for 38 medicines

Price decreases for 38 medicines
PTC Therapeutics announce the launch of Emflaza for the treatment of Duchenne muscular dystrophy (DMD) within the coming weeks, with an expected net price of $35,000.
The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment
The PBS, Australia’s national program responsible for providing subsidised prescriptions, has announced the addition of several new medicines